(Q45081906)

9 December 2017

title

Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons (English)

1 reference

9 December 2017

0 references

5

1 reference

9 December 2017

author name string

Tomás González-Hernández

1

1 reference

9 December 2017

Pedro Barroso-Chinea

2

1 reference

9 December 2017

Ignacio De La Cruz Muros

3

1 reference

9 December 2017

María Del Mar Pérez-Delgado

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

The Journal of Comparative Neurology

9 December 2017

published in

1 reference

9 December 2017

volume

479

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

198-215

1 reference

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

9 December 2017

cites work

1 reference

Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.

21 January 2018

1 reference

Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals.

21 January 2018

1 reference

Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon

21 January 2018

1 reference

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease

21 January 2018

1 reference

Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes.

21 January 2018

1 reference

Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain

21 January 2018

1 reference

Dendritic release of dopamine in the substantia nigra

21 January 2018

1 reference

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

21 January 2018

1 reference

Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.

21 January 2018

1 reference

Immunocytochemical localization of the dopamine transporter in human brain

21 January 2018

1 reference

Medial dorsal striatum is more sensitive than lateral dorsal striatum to cocaine inhibition of exogenous dopamine clearance: relation to [3H]mazindol binding, but not striosome/matrix.

21 January 2018

1 reference

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

21 January 2018

1 reference

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

21 January 2018

1 reference

Parkinson's disease: mechanisms and models

21 January 2018

1 reference

Molecular Pathways of Neurodegeneration in Parkinson's Disease

21 January 2018

1 reference

Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat.

21 January 2018

1 reference

On counting and counting errors

21 January 2018

1 reference

Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates

21 January 2018

1 reference

Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

21 January 2018

1 reference

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix.

21 January 2018

1 reference

The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum

21 January 2018

1 reference

Pharmacological and biochemical studies with three metabolites of nomifensine

21 January 2018

1 reference

Effect of nomifensine on the toxicity of 6-hydroxydopamine for mesotelencephalic dopamine neurons.

21 January 2018

1 reference

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra

21 January 2018

1 reference

Up- and down-expression of the dopamine transporter by plasmid DNA transfer in the rat brain.

21 January 2018

1 reference

The midbrain dopaminergic cell groups in the baboon Papio ursinus.

21 January 2018

1 reference

Dopamine transporters and neuronal injury

21 January 2018

1 reference

Motor behavioural changes after intracerebroventricular injection of 6-hydroxydopamine in the rat: an animal model of Parkinson's disease

21 January 2018

1 reference

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease

21 January 2018

1 reference

Effect of novel stressors on gene expression of tyrosine hydroxylase and monoamine transporters in brainstem noradrenergic neurons of long-term repeatedly immobilized rats

21 January 2018

1 reference

The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.

21 January 2018

1 reference

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration

21 January 2018

1 reference

Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

21 January 2018

1 reference

Dopamine transporter mRNA: dense expression in ventral midbrain neurons

21 January 2018

1 reference

The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter.

21 January 2018

1 reference

Differential time course of protection by monoamine oxidase inhibition and uptake inhibition against MPTP neurotoxicity on central catecholamine neurons in mice.

21 January 2018

1 reference

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

21 January 2018

1 reference

Estimation of nuclear population from microtome sections

21 January 2018

1 reference

7 January 2021

Astrocytes as a primary locus for the conversion MPTP into MPP+

1 reference

7 January 2021

Differences in dopamine clearance and diffusion in rat striatum and nucleus accumbens following systemic cocaine administration.

1 reference

7 January 2021

Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors.

1 reference

7 January 2021

The dopamine transporter: immunochemical characterization and localization in brain

1 reference

7 January 2021

Neural degeneration and the transport of neurotransmitters

1 reference

7 January 2021

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 reference

7 January 2021

Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum

1 reference

7 January 2021

Ageing and Parkinson's disease: substantia nigra regional selectivity

1 reference

7 January 2021

Dopamine transporter immunoreactivity in rat brain

1 reference

7 January 2021

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

7 January 2021

Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice.

1 reference

7 January 2021

The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.

1 reference

7 January 2021

Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization

1 reference

7 January 2021

Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells

1 reference

7 January 2021

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

1 reference

7 January 2021

Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration

1 reference

7 January 2021

Self-inhibition by Dopaminergic Neurons

1 reference

7 January 2021

Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity

1 reference

7 January 2021

GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys

1 reference

7 January 2021

Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum

1 reference

7 January 2021

The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons

1 reference

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

7 January 2021

Understanding cell death in Parkinson's disease.

1 reference

7 January 2021

6-Hydroxydopamine Lesion of the Rat Substantia Nigra: Time Course and Morphology of Cell Death

1 reference

7 January 2021

A simple and sensitive antigen retrieval method for free-floating and slide-mounted tissue sections

1 reference

7 January 2021

Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region

1 reference

7 January 2021

Preservation of midbrain catecholaminergic neurons in very old human subjects

1 reference

7 January 2021

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

1 reference

7 January 2021

Central effects of 6-hydroxydopamine

1 reference

7 January 2021

Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans

1 reference

7 January 2021

Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.

1 reference

7 January 2021

The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons

1 reference

7 January 2021

Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium.

1 reference

7 January 2021

Multiple antioxidants in the prevention and treatment of Parkinson's disease

1 reference

7 January 2021

Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.

1 reference

7 January 2021

Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration

1 reference

7 January 2021

Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism by the catecholamine uptake inhibitor nomifensine: behavioral analysis in monkeys with partial striatal dopamine depletions

1 reference

7 January 2021

Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons

1 reference

7 January 2021

Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease

1 reference

7 January 2021

Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT

1 reference

7 January 2021

Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions

1 reference

7 January 2021

Identifiers

DOI

10.1002/CNE.20323

1 reference

release_2m37nv2p7zbbtmt33if2im6mvm

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2m37nv2p7zbbtmt33if2im6mvm

24 November 2022

mapped directly with Wikidata item

1 reference